IL94939A - Transformed Analogs of Maginin Peptide and Their Use - Google Patents

Transformed Analogs of Maginin Peptide and Their Use

Info

Publication number
IL94939A
IL94939A IL9493990A IL9493990A IL94939A IL 94939 A IL94939 A IL 94939A IL 9493990 A IL9493990 A IL 9493990A IL 9493990 A IL9493990 A IL 9493990A IL 94939 A IL94939 A IL 94939A
Authority
IL
Israel
Prior art keywords
lys
ala
magainin
peptide
amino acid
Prior art date
Application number
IL9493990A
Other languages
English (en)
Hebrew (he)
Other versions
IL94939A0 (en
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of IL94939A0 publication Critical patent/IL94939A0/xx
Publication of IL94939A publication Critical patent/IL94939A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9493990A 1989-07-07 1990-07-02 Transformed Analogs of Maginin Peptide and Their Use IL94939A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37675489A 1989-07-07 1989-07-07

Publications (2)

Publication Number Publication Date
IL94939A0 IL94939A0 (en) 1991-06-10
IL94939A true IL94939A (en) 1996-12-05

Family

ID=23486335

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9493990A IL94939A (en) 1989-07-07 1990-07-02 Transformed Analogs of Maginin Peptide and Their Use

Country Status (16)

Country Link
EP (4) EP0751148A3 (fr)
JP (1) JP2854970B2 (fr)
CN (1) CN1055480C (fr)
AT (1) ATE146188T1 (fr)
AU (1) AU650236B2 (fr)
CA (1) CA2020663C (fr)
DE (1) DE69029377T2 (fr)
DK (1) DK0437556T3 (fr)
ES (1) ES2095255T3 (fr)
IE (1) IE63842B1 (fr)
IL (1) IL94939A (fr)
PH (4) PH30054A (fr)
PT (1) PT94625B (fr)
SG (1) SG47913A1 (fr)
WO (1) WO1991000869A1 (fr)
ZA (1) ZA905203B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650236B2 (en) * 1989-07-07 1994-06-16 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
JPH06511234A (ja) * 1991-06-12 1994-12-15 マゲイニン　ファーマス−ティカルズ，インコーポレーテッド Ｃ末端置換を有する生物活性ペプチド組成物および治療法
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
CN101928340A (zh) * 2009-12-24 2010-12-29 深圳市圣西马生物技术有限公司 一组抗菌肽衍生物及其应用
CN104710523B (zh) * 2013-12-11 2017-12-29 华东理工大学 对铜绿假单胞菌具有抗菌性能的Magainin肽修饰物及其制备方法
MX2017016251A (es) * 2015-07-02 2018-04-20 Dana Farber Cancer Inst Inc Peptidos anti-microbianos estabilizados.
CN109069578A (zh) 2016-02-29 2018-12-21 达纳-法伯癌症研究所股份有限公司 用于治疗感染的钉合的细胞内靶向抗微生物肽
US11325955B2 (en) 2017-07-19 2022-05-10 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
CN111892646B (zh) * 2020-08-13 2023-05-02 中国人民解放军军事科学院军事医学研究院 抗菌肽衍生物及其在制备抗细菌感染药物中的应用
CN112625092B (zh) * 2021-01-13 2023-03-28 兰州大学 一种基于polybia-MPI的抗菌多肽化合物及其合成与应用
CN114634553B (zh) * 2022-04-27 2024-03-08 贵州医科大学 阳离子肽c9及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2515763B2 (ja) * 1986-11-17 1996-07-10 株式会社小松製作所 埋設物探査方法
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
JP2555174B2 (ja) * 1987-03-04 1996-11-20 アメリカ合衆国 新規の合成生物活性化合物および生物活性効果を生ずる方法
AU650236B2 (en) * 1989-07-07 1994-06-16 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides

Also Published As

Publication number Publication date
IE902476A1 (en) 1991-02-13
PH30410A (en) 1997-05-09
DK0437556T3 (da) 1996-12-30
ES2095255T3 (es) 1997-02-16
PH30219A (en) 1997-02-05
IL94939A0 (en) 1991-06-10
PH30218A (en) 1997-02-05
CA2020663C (fr) 1999-12-07
DE69029377D1 (de) 1997-01-23
AU650236B2 (en) 1994-06-16
PT94625A (pt) 1991-03-20
DE69029377T2 (de) 1997-06-19
EP0761684A2 (fr) 1997-03-12
JPH04506801A (ja) 1992-11-26
ZA905203B (en) 1991-05-29
EP0751148A2 (fr) 1997-01-02
EP0751148A3 (fr) 1997-07-02
EP0437556A1 (fr) 1991-07-24
EP0761684A3 (fr) 1997-07-02
CN1049166A (zh) 1991-02-13
EP0751149A2 (fr) 1997-01-02
AU5945490A (en) 1991-02-06
EP0437556A4 (en) 1992-05-20
EP0437556B1 (fr) 1996-12-11
CA2020663A1 (fr) 1991-01-08
PT94625B (pt) 1997-03-31
JP2854970B2 (ja) 1999-02-10
ATE146188T1 (de) 1996-12-15
CN1055480C (zh) 2000-08-16
EP0751149A3 (fr) 1997-07-02
IE63842B1 (en) 1995-06-14
PH30054A (en) 1996-11-08
SG47913A1 (en) 1998-04-17
WO1991000869A1 (fr) 1991-01-24

Similar Documents

Publication Publication Date Title
US5294605A (en) Amphiphilic peptide compositions and analogues thereof
US4962277A (en) Deletion analogues of magainin peptides
EP0437556B1 (fr) Analogues de substitution des peptides de la magainine
JPH05163298A (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
EP1386928B1 (fr) Derive peptidique antibacterien de peau de grenouille
US7723467B2 (en) Antimicrobial compounds
US5912231A (en) Substitution analogues of magainin peptides
EP2548883A2 (fr) Composés peptidiques utiles en tant qu'agents antibactériens
CN102766196B (zh) 一组阳离子抗菌肽及其制备方法和应用
WO1998016549A1 (fr) Analogues de peptides anti-microbiens de gramicidine s et compositions contenant ces analogues
JPH03504501A (ja) 両親媒性ペプチドとその用途
CA2047317A1 (fr) Compositions peptidiques amphiphiliques et leurs analogues
WO1991019512A1 (fr) Peptides antimicrobiens
WO2024037263A1 (fr) Peptide synthétique ayant une faible toxicité in vivo pour inhiber la génération de toxines de staphylococcus aureus et son utilisation
EP0734394A1 (fr) Inhibiteurs peptidiques de molecules de la famille des intercrines cxc
JPH0656889A (ja) 新規ペプチドおよび抗菌剤
CN115010788A (zh) N-末端脂肪酸修饰的具有抗生物膜活性的低毒广谱抗菌肽类似物及其应用
JPH06199893A (ja) 新規ペプチドおよび抗菌剤
JPH0656888A (ja) 新規ペプチドおよび抗菌剤
JP2005532784A (ja) 新規の抗菌ボリシンペプチド
NO904846L (no) Amfifile peptider og anvendelse derav.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed